Teva, Allergan Finalize Multibillion-Dollar Global Opioid Deals

By Emily Field (November 22, 2022, 9:25 AM EST) -- Teva on Tuesday said that it had finalized a global deal worth up to $4.25 billion to end allegations brought by states and local governments that it fueled the opioid crisis by downplaying the risks of addiction, in addition to Allergan saying it finalized its own deal worth up to $2.02 billion....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!